Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Clinterooon Jan 10, 2014 4:30pm

116 Views

Post# 22079842

RE:p.p.

I doubt they would lower the price. The PP was only announced two days ago.

I am not sure if there is a never ending supply at .15 or not but what we really need is some volume. For the past several weeks we have averaged about 100,000 shares. A mere $15,000. We need more volume, ie. a million or more shares traded for a few days.

The PP has not had any real effect on voume.

So I guess the market is not as enamoured about the PP as homerun is. Gee, what a surprise.

Anyway, I think the bottom line is we still need to finalize the deals with Obagi and Wanbang. All else is secondary. Yes the PP ensures we have money for the next while but without deals we have nothing.

Bullboard Posts

This junior mining stock offers billions in market exposure